A Prospective Observational Study to Evaluate Long-term Changes in Cartilage Morphology in Subjects Who Previously Received TPX-100 or Placebo in Study TPX-100-1 for Patellar Osteoarthritis Involving Both Knees
Phase of Trial: Phase IV
Latest Information Update: 17 Apr 2018
Price : $35 *
At a glance
- Drugs TPX 100 (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors OrthoTrophix
- 17 Apr 2018 According to an OrthoTrophix media release, data will be presented at the 2018 OARSI annual meeting.
- 04 Apr 2018 Status changed from recruiting to completed.
- 18 Sep 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Oct 2017.